DROTONEX DT TAB - Dr Precision

DROTONEX DT Tablet is a highly effective oral medication designed to manage nausea, vomiting, bloating, and gastric motility disturbances, especially when associated with delayed gastric emptying. Each dispersible tablet contains Domperidone 10 mg, a well-established dopamine D2 receptor antagonist that acts both centrally (in the chemoreceptor trigger zone) and peripherally (in the GI tract) to reduce nausea and improve gastric movement.

As a dispersible formulation, DROTONEX DT provides a key advantage in quick disintegration in the oral cavity, eliminating the need for water and enabling rapid onset of action. This makes it ideal for patients experiencing acute episodes of nausea, children, the elderly, or those with difficulty swallowing conventional tablets.

Produced by BluepillExpress, a globally recognized pharmaceutical manufacturer and exporter, DROTONEX DT is formulated under WHO-GMP certified facilities, ensuring international quality standards. It is ideal for export, institutional supply, and private labeling projects across global markets including Africa, Latin America, Asia, and CIS nations.

The core therapeutic benefit of Domperidone lies in its dual action: it helps block dopamine receptors in the brain to prevent vomiting and also enhances gastrointestinal motility, making it especially useful for functional dyspepsia, GERD, and nausea induced by drugs or GI infections.

Key Features & Benefits

Active Ingredient: Domperidone 10 mg

Formulation Type: Fast-dispersing oral tablet

Therapeutic Action: Antiemetic, Prokinetic

Onset of Relief: Within 30 minutes

Disintegration: Quick oral disintegration—ideal for on-the-go use

Patient-Friendly: No water required; suitable for pediatric and geriatric use

Mechanism of Action

Domperidone works by blocking dopamine (D2) receptors in the chemoreceptor trigger zone (CTZ) of the brain and in the gut. This dual action helps:

Suppress nausea and vomiting

Improve peristalsis and stomach emptying

Relieve fullness, bloating, and early satiety

Clinical Applications

Acute and chronic nausea

Vomiting caused by GI infections, food intolerance, or medication

Functional dyspepsia

Gastroesophageal reflux disease (GERD)

Gastric bloating and fullness

Post-operative or drug-induced gastric stasis

Suitable as adjunct in migraine therapy to enhance GI absorption of painkillers